Advanced Molecular Detection for Improving Public’s Health
Presented on .
Advances in science and technology aimed at identifying the genetic makeup of microorganisms will build CDC’s capacity to prevent illness and save lives. CDC estimates that 1 in 6 Americans—or 48 million people—get sick from contaminated food each year—costing the United States $77 billion per year in health care treatment, workplace, and other economic losses. Additionally, in the United States, the number of outbreaks involving drug-resistant microbes is on the rise. Although they are still highly valuable, CDC’s current methods are limiting our ability for better and more rapid detection of these microbes.
This session of Grand Rounds explored opportunities for CDC to leverage key aspects of Advanced Molecular Detection (AMD), bioinformatics and enhanced molecular tools, such as whole genome sequence, to improve our ability to diagnose/identify infectious diseases, investigate and control outbreaks, understand transmission patterns, develop and target vaccines, and determine antimicrobial resistance—all with increased timeliness, accuracy and decreased costs.
Dr. Tanja Popovic and Dr. Duncan MacCannell discuss the application of Advanced Molecular Detection technologies such as genomic sequencing and bioinformatics. These technologies will yield key benefits to public health such as:
- Improved Detection
- More detailed identification of antimicrobial resistance
- Better Outbreak Investigation
- Duncan MacCannell, PhD
- Senior Advisor for Bioinformatics
National Center for Emerging and Zoonotic Diseases, CDC
- James Posey, PhD
- Lead, Applied Research Team, Laboratory Branch
Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
- Michael W. Shaw, PhD
- Associate Director of Laboratory Science, Influenza Division
National Center for Immunization and Respiratory Diseases, CDC
- John R. McQuiston, PhD
- Team Lead, Special Bacteriology Reference Laboratory
Bacterial Special Pathogens Branch
Division of High Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Diseases, CDC
- David Engelthaler, MS
- Director, TGen North
Translational Genomics Research Institute
- Tanja Popovic, MD, PhD
- Scientific Director
- John Iskander, MD, MPH
- Deputy Scientific Director
- Susan Laird, MSN, RN
- Communications Director
Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!
Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up
Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!